Home  > 
  CHMP recommends approval of Bristol-Myers' bladder cancer drug Opdivo,   April 24, 2017
  NuVasive launches new spinal trauma portfolio,   April 22, 2017
  Japanese pharma companies forecast to have 17% growth in 2017,   April 21, 2017
  PSI, Pfizer collaborate to address hypertension in Vietnam & Myanmar,   April 21, 2017
  Eyevensys receives UK MHRA approval to advance its EyeCET platform into clinical development,   April 21, 2017
  Omnicell completes acquisition of Mississippi-based nPharmics,   April 20, 2017
  Japan Vaccine Co seeks Japanese approval for Shingrix for prevention of shingles,   April 20, 2017
  Rigel Pharma submits NDA to US FDA for fostamatinib in patients with chronic ITP,   April 20, 2017
  Roche‚Äôs Tecentriq receives US FDA accelerated approval to treat certain people with advanced bladder cancer,   April 20, 2017
  Cardinal Health to buy Medtronic's patient care, deep vein thrombosis & nutritional insufficiency businesses for $6.1 billion,   April 19, 2017
  Novotech signs MoU with South Korea's AMC to promote clinical research capabilities internationally,   April 19, 2017
  Egalet announces US FDA accepts prior approval supplement filing for Oxaydo tablets C-II 10 & 15 mg dosage strengths,   April 19, 2017
  AMAG seeks US FDA approval for Makena auto-injector for subcutaneous use,   April 19, 2017
  Enzyvant's tissue-based therapy, RVT-802 to treat complete DiGeorge syndrome gets US FDA breakthrough therapy & RMAT designations,   April 19, 2017
  US FDA grants breakthrough therapy status to Novartis CAR-T cell therapy CTL019 to treat adult patients with r/r DLBCL,   April 19, 2017
  US FDA seeks additional data from Eli Lilly & Incyte on baricitinib NDA to treat rheumatoid arthritis,   April 17, 2017
  AUA, ASCO, ASTRO and SUO release new clinical guideline on non-metastatic muscle-invasive bladder cancer,   April 15, 2017
  Biogen licenses BMS-986168, phase 2 anti-tau antibody from Bristol-Myers Squibb,   April 15, 2017
  BioCryst plans to explore new oral liquid formulation of BCX7353 to treat acute attacks in HAE patients,   April 14, 2017
  Florida Institute funds Pensacola-based VetCV,   April 12, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |